Kalvista
3 known investors
KalVista is a pharmaceutical company developing orally-delivered small molecule medicines, with an initial focus on treatments for people living with hereditary angioedema (HAE). It works to expand treatment options beyond current therapies for patients with this and other diseases.
BiotechHealthtech
Investors Β· 3
In the news
Frequently asked questions
- What does Kalvista do?
- KalVista is a pharmaceutical company developing orally-delivered small molecule medicines, with an initial focus on treatments for people living with hereditary angioedema (HAE). It works to expand treatment options beyond current therapies for patients with this and other diseases.
- Who are Kalvista's investors?
- Kalvista's investors include Frazier Life Sciences, Longwood Fund, RA Capital.